These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38820867)
41. 177 Lu-PSMA-617 radioligand therapy of metastatic castration-resistant prostate cancer: Initial 254-patient results from a prospective registry (REALITY Study). Khreish F; Ghazal Z; Marlowe RJ; Rosar F; Sabet A; Maus S; Linxweiler J; Bartholomä M; Ezziddin S Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1075-1085. PubMed ID: 34494131 [TBL] [Abstract][Full Text] [Related]
42. Comparison of voxel S-value methods for personalized voxel-based dosimetry of Kim KM; Lee MS; Suh MS; Selvam HSMS; Tan TH; Cheon GJ; Kang KW; Lee JS Med Phys; 2022 Mar; 49(3):1888-1901. PubMed ID: 35014699 [TBL] [Abstract][Full Text] [Related]
43. Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. Brosch-Lenz J; Uribe C; Gosewisch A; Kaiser L; Todica A; Ilhan H; Gildehaus FJ; Bartenstein P; Rahmim A; Celler A; Ziegler S; Böning G EJNMMI Phys; 2021 Mar; 8(1):26. PubMed ID: 33709253 [TBL] [Abstract][Full Text] [Related]
45. Factors affecting accuracy of S values and determination of time-integrated activity in clinical Lu-177 dosimetry. Götz TI; Schmidkonz C; Lang EW; Maier A; Kuwert T; Ritt P Ann Nucl Med; 2019 Jul; 33(7):521-531. PubMed ID: 31119607 [TBL] [Abstract][Full Text] [Related]
46. Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated Gupta A; Shin JH; Lee MS; Park JY; Kim K; Kim JH; Suh M; Park CR; Kim YJ; Song MG; Jeong JM; Lee DS; Lee YS; Lee JS Mol Pharm; 2019 Apr; 16(4):1498-1506. PubMed ID: 30821463 [TBL] [Abstract][Full Text] [Related]
47. Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer: One Center Results. Özkan A; Uçar B; Seymen H; Yildiz Yarar Y; Falay FO; Demirkol MO Clin Nucl Med; 2020 Apr; 45(4):288-291. PubMed ID: 32049721 [TBL] [Abstract][Full Text] [Related]
48. Evaluation of Pathmanandavel S; Crumbaker M; Ho B; Yam AO; Wilson P; Niman R; Ayers M; Sharma S; Hickey A; Eu P; Stockler M; Martin AJ; Joshua AM; Nguyen A; Emmett L J Nucl Med; 2023 Feb; 64(2):221-226. PubMed ID: 36008120 [No Abstract] [Full Text] [Related]
49. Radioligand Therapy With Yadav MP; Ballal S; Sahoo RK; Dwivedi SN; Bal C AJR Am J Roentgenol; 2019 Aug; 213(2):275-285. PubMed ID: 30995089 [No Abstract] [Full Text] [Related]
50. Pre-therapeutic dosimetry of normal organs and tissues of (177)Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer. Kabasakal L; AbuQbeitah M; Aygün A; Yeyin N; Ocak M; Demirci E; Toklu T Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1976-83. PubMed ID: 26227531 [TBL] [Abstract][Full Text] [Related]
59. Early response monitoring during [ Neubauer MC; Nicolas GP; Bauman A; Fani M; Nitzsche E; Afshar-Oromieh A; Forrer F; Rentsch C; Stenner F; Templeton A; Schäfer N; Wild D; Chirindel A; Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1185-1193. PubMed ID: 38038755 [TBL] [Abstract][Full Text] [Related]
60. TestDose: A nuclear medicine software based on Monte Carlo modeling for generating gamma camera acquisitions and dosimetry. Garcia MP; Villoing D; McKay E; Ferrer L; Cremonesi M; Botta F; Ferrari M; Bardiès M Med Phys; 2015 Dec; 42(12):6885-94. PubMed ID: 26632045 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]